Long-term outcome of resuming anticoagulation after anticoagulation-associated intracerebral hemorrhage

Introduction: The risk and benefit of restarting oral anticoagulation (OAC) therapy among patients with atrial fibrillation or flutter (AF) and an episode of anticoagulation-associated intracerebral hemorrhage (ICH) remain unclear. Whether or not to resume OAC after an OAC-associated ICH will remain...

Full description

Bibliographic Details
Main Authors: Alireza Sadighi, Lisa Wasko, Heather DiCristina, Thomas Wagner, Kathryn Wright, Kellie Capone, Maureen Monczewski, Margaret Kester, George Bourdages, Christoph Griessenauer, Ramin Zand
Format: Article
Language:English
Published: Elsevier 2020-03-01
Series:eNeurologicalSci
Online Access:http://www.sciencedirect.com/science/article/pii/S2405650220300010